IP Library Granted Patent US 9,814,671
Granted Patent B2
US 9,814,671 · App. 14/770,494 · Granted Nov 14, 2017

Drug delivery devices and methods for drug delivery

Inventor: Heejin Lee (Bedford, MA)
Assignee: TARIS Biomedical LLC
A61K9/0004A61K9/0034A61K31/167A61M31/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,814,671
App. No.
14/770,494
Granted
Nov 14, 2017
Kind
B2
Abstract

An orifice-free drug delivery device is provided. In an embodiment, the device includes a body having at least one water-permeable wall bounding a reservoir defined within the body. A drug formulation is disposed within the reservoir. The body has an elastic portion and at least one restraining plug closing off an opening of the body. The opening is in fluid communication with the reservoir, and the restraining plug contacts the elastic portion of the body and controls release of the drug from the device by the transient formation of one or more microchannels between the elastic portion of the body and the at least one restraining plug. The elastic portion may define an opening having an inner diameter, which is exceeded by the outer diameter of the restraining plug by at least 3%.

Claims (37)

1. A drug delivery device comprising:

a body having at least one water permeable wall bounding a reservoir defined within the body, wherein the body comprises an elastic portion;

a drug formulation which comprises a drug, the drug formulation being disposed within the reservoir; and

at least one restraining plug closing off an opening of the body, the opening being in fluid communication with the reservoir,

wherein the at least one restraining plug contacts the elastic portion of the body and controls release of the drug from the device by the transient formation of one or more microchannels between the elastic portion of the body and the at least one restraining plug, and

wherein the one or more microchannels are not preformed orifices.

2. The drug delivery device of claim 1 , wherein:

the at least one restraining plug has an outer diameter,

the elastic portion of the body defines an opening having an inner diameter, and

wherein the outer diameter of the restraining plug exceeds the inner diameter of the elastic portion of the body by at least 3%.

3. The drug delivery device of claim 2 , wherein the outer diameter of the restraining plug exceeds the inner diameter of the elastic portion of the body by at least 5%.

4. The drug delivery device of claim 2 , wherein the outer diameter of the restraining plug exceeds the inner diameter of the elastic portion of the body by at least 10%.

5. The drug delivery device of claim 2 , wherein the outer diameter of the restraining plug exceeds the inner diameter of the elastic portion of the body by at least 15%.

6. The drug delivery device of claim 2 , wherein the outer diameter of the restraining plug exceeds the inner diameter of the elastic portion of the body by at least 20%.

7. The drug delivery device of claim 2 , wherein the outer diameter of the restraining plug exceeds the inner diameter of the elastic portion of the body by at least 25%.

8. The drug delivery device of claim 1 , wherein the body further comprises an inelastic portion.

9. The drug delivery device of claim 1 , wherein the at least one restraining plug is secured within the opening in the elastic portion of the body with an adhesive.

10. The drug delivery device of claim 1 , wherein the drug formulation is in a solid form.

11. The drug delivery device of claim 1 , wherein the drug comprises lidocaine or another anesthetic agent.

12. The drug delivery device of claim 1 , further comprising an osmotic agent.

13. The drug delivery device of claim 12 , wherein the osmotic agent is a component of the drug formulation.

14. The drug delivery device of claim 1 , wherein the at least one restraining plug is substantially cylindrical.

15. The drug delivery device of claim 1 , wherein the at least one restraining plug comprises a wedged, tapered, angled, or rounded surface.

16. The drug delivery device of claim 1 , wherein the Shore durometer of the elastic portion of the body is from about 40 A to about 60 A, and the Shore durometer of the at least one restraining plug is from about 70 A to about 100 A.

17. The drug delivery device of claim 1 , wherein the Shore durometer of the elastic portion of the body is from about 45 A to about 55 A, and the Shore durometer of the at least one restraining plug is from about 75 A to about 85 A.

18. The drug delivery device of claim 1 , wherein the Shore durometer of the elastic portion of the body is about 50 A, and the Shore durometer of the at least one restraining plug is about 80 A.

19. The drug delivery device of claim 1 , wherein the device is elastically deformable between a relatively straightened shape suitable for insertion through a lumen into a body cavity of a patient and a retention shape suited to retain the device within the body cavity.

20. A method of administering a drug to a patient, comprising:

inserting the drug delivery device of claim 1 into a lumen or body cavity of a patient; and

permitting water influx into the reservoir to develop a hydrostatic pressure in the reservoir effective to form one or more microchannels between the elastic portion of the body and the at least one restraining plug, thereby causing the drug to flow from the reservoir, through the microchannels, and out of the device and into the lumen or body cavity.

21. The method of claim 20 , wherein the body cavity is the bladder of the patient.

22. A drug delivery device comprising:

a body having at least one water-permeable wall bounding a reservoir defined within the body, wherein the at least one water-permeable wall comprises an elastic portion;

a solid drug formulation which comprises a drug, the drug formulation being disposed within the reservoir; and

at least one restraining plug closing off an opening of the body, the opening being in fluid communication with the reservoir,

wherein the at least one restraining plug contacts the elastic portion of the at least one water-permeable wall and controls release of the drug from the device by the transient formation of one or more microchannels between the elastic portion of the at least one water-permeable wall and the at least one restraining plug, and

wherein the one or more microchannels are not preformed orifices.

Assignments (1)
MERGER Recorded Jun 1, 2026
From: TARIS BIOMEDICAL LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 074810/0801 →
Continuity (2)
Provisional Application 61794677 · Mar 15, 2013
Related Publication 20160008271A1 · Jan 14, 2016